(Q37625900)

21 August 2017

1 reference

title

Warfarin anticoagulation reversal: management of the asymptomatic and bleeding patient (English)

1 reference

21 August 2017

1 reference

1 reference

1 reference

Michael Makris

1

1 reference

21 August 2017

Joost J van Veen

series ordinal

2

1 reference

21 August 2017

Rhona Maclean

series ordinal

3

1 reference

21 August 2017

publication date

1 February 2010

1 reference

Journal of Thrombosis and Thrombolysis

21 August 2017

published in

1 reference

21 August 2017

volume

29

1 reference

21 August 2017

issue

2

1 reference

21 August 2017

page(s)

171-181

1 reference

Clinical predictors of prolonged delay in return of the international normalized ratio to within the therapeutic range after excessive anticoagulation with warfarin

21 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11239-009-0412-5

Antagonism of warfarin-induced hypoprothrombinemia with use of low-dose subcutaneous vitamin K1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-009-0412-5

Oral vitamin K lowers the international normalized ratio more rapidly than subcutaneous vitamin K in the treatment of warfarin-associated coagulopathy. A randomized, controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-009-0412-5

Management of excessive anticoagulant effect due to vitamin K antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-009-0412-5

Oral vitamin K versus placebo to correct excessive anticoagulation in patients receiving warfarin: a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-009-0412-5

Emergency reversal of anticoagulation after intracerebral hemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-009-0412-5

What is the evidence for the off-label use of recombinant factor VIIa (rFVIIa) in the acute reversal of warfarin? ASH evidence-based review 2008.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-009-0412-5

Prospective study of the outcomes of ambulatory patients with excessive warfarin anticoagulation.

21 January 2018

1 reference

12 December 2020

The use of oral vitamin K for reversal of over-warfarinization

1 reference

12 December 2020

Randomized, placebo-controlled trial of oral phytonadione for excessive anticoagulation.

1 reference

12 December 2020

Clinical classification schemes for predicting hemorrhage: results from the National Registry of Atrial Fibrillation (NRAF).

1 reference

12 December 2020

Bleeding complications of oral anticoagulant treatment: an inception-cohort, prospective collaborative study (ISCOAT). Italian Study on Complications of Oral Anticoagulant Therapy

1 reference

12 December 2020

The risk of overanticoagulation with antibiotic use in outpatients on stable warfarin regimens

1 reference

12 December 2020

Prediction of the risk of bleeding during anticoagulant treatment for venous thromboembolism

1 reference

12 December 2020

Genetic testing before anticoagulation? A systematic review of pharmacogenetic dosing of warfarin

1 reference

12 December 2020

Use of factor IX complex in warfarin-related intracranial hemorrhage

1 reference

12 December 2020

A comparison of the efficacy and rate of response to oral and intravenous Vitamin K in reversal of over-anticoagulation with warfarin

1 reference

12 December 2020

Prospective evaluation of an index for predicting the risk of major bleeding in outpatients treated with warfarin

1 reference

12 December 2020

Ultra-rapid management of oral anticoagulant therapy-related surgical intracranial hemorrhage

1 reference

12 December 2020

The risk of hemorrhage among patients with warfarin-associated coagulopathy

1 reference

12 December 2020

Treatment of warfarin-associated coagulopathy with oral vitamin K: a randomised controlled trial.

1 reference

12 December 2020

Comparison of oral vs intravenous phytonadione (vitamin K1) in patients with excessive anticoagulation: a prospective randomized controlled study

1 reference

12 December 2020

Low-dose oral vitamin K reliably reverses over-anticoagulation due to warfarin.

1 reference

12 December 2020

Major bleeding in outpatients treated with warfarin: incidence and prediction by factors known at the start of outpatient therapy

1 reference

12 December 2020

Conservative treatment of overanticoagulated patients

1 reference

12 December 2020

Evaluation of excessive anticoagulation in a group model health maintenance organization

1 reference

12 December 2020

A comparison of two intensities of warfarin for the prevention of recurrent thrombosis in patients with the antiphospholipid antibody syndrome

1 reference

12 December 2020

Reversal of excessive effect of regular anticoagulation: low oral dose of phytonadione (vitamin K1) compared with warfarin discontinuation

1 reference

12 December 2020

Low dose oral vitamin K to reverse acenocoumarol-induced coagulopathy: a randomized controlled trial.

1 reference

12 December 2020

Major bleeding after hospitalization for deep-venous thrombosis.

1 reference

12 December 2020

The incidence of anaphylaxis following intravenous phytonadione (vitamin K1): a 5-year retrospective review

1 reference

12 December 2020

The use of oral vitamin K for reversal of over-warfarinization

1 reference

12 December 2020

Safety and effectiveness of low dose oral vitamin K1 administration in asymptomatic out-patients on warfarin or acenocoumarol with excessive anticoagulation

1 reference

12 December 2020

Retrospective and prospective analyses of the treatment of overanticoagulated patients

1 reference

12 December 2020

Role of prothrombin complex concentrates in reversing warfarin anticoagulation: a review of the literature

1 reference

12 December 2020

Optimal oral anticoagulant therapy in patients with mechanical heart valves.

1 reference

12 December 2020

The risk for and severity of bleeding complications in elderly patients treated with warfarin. The National Consortium of Anticoagulation Clinics

1 reference

12 December 2020

Safety of treatment with oral anticoagulants in the elderly. A systematic review

1 reference

12 December 2020

Time course of reversal of anticoagulant effect of warfarin by intravenous and subcutaneous phytonadione

1 reference

12 December 2020

Comparison of low-intensity warfarin therapy with conventional-intensity warfarin therapy for long-term prevention of recurrent venous thromboembolism

1 reference

12 December 2020

Prothrombin complex concentrate for oral anticoagulant reversal in neurosurgical emergencies

1 reference

12 December 2020

Safety of anticoagulation therapy in well-informed older patients.

1 reference

12 December 2020

Warfarin reversal emerging as the major indication for fresh frozen plasma use at a tertiary care hospital

1 reference

12 December 2020

Prediction of hemorrhagic and thrombotic events in patients with mechanical heart valve prostheses treated with oral anticoagulants.

1 reference

12 December 2020

Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients

1 reference

12 December 2020

A randomized trial comparing 1 mg of oral vitamin K with no treatment in the management of warfarin-associated coagulopathy in patients with mechanical heart valves

1 reference

12 December 2020

Suboptimal effect of a three-factor prothrombin complex concentrate (Profilnine-SD) in correcting supratherapeutic international normalized ratio due to warfarin overdose

1 reference

12 December 2020

A prospective randomized study to determine the optimal dose of intravenous vitamin K in reversal of over-warfarinization.

1 reference

12 December 2020

Emergency oral anticoagulant reversal: the relative efficacy of infusions of fresh frozen plasma and clotting factor concentrate on correction of the coagulopathy.

1 reference

12 December 2020

Anticoagulation therapy for stroke prevention in atrial fibrillation: how well do randomized trials translate into clinical practice?

1 reference

12 December 2020

Increased risk of intracranial hemorrhage when aspirin is combined with warfarin: A meta-analysis and hypothesis

1 reference

12 December 2020

Effective reversal of warfarin-induced excessive anticoagulation with low dose vitamin K1

1 reference

12 December 2020

Reversal of excessive oral anticoagulation with a low oral dose of vitamin K1 compared with acenocoumarine discontinuation. A prospective, randomized, open study

1 reference

12 December 2020

Subcutaneous phytonadione for reversal of warfarin-induced elevation of the International Normalized Ratio.

1 reference

12 December 2020

Treatment of excessive anticoagulation with phytonadione (vitamin K): a meta-analysis

1 reference

12 December 2020

Pharmacology and management of the vitamin K antagonists: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).

1 reference

12 December 2020

A multicentre randomised assessment of the DAWN AC computer-assisted oral anticoagulant dosage program.

1 reference

12 December 2020

Lowering the intensity of oral anticoagulant therapy: effects on the risk of hemorrhage and thromboembolism

1 reference

12 December 2020

Intravenous versus subcutaneous vitamin K1 in reversing excessive oral anticoagulation.

1 reference

12 December 2020

Use of recombinant activated factor VII in patients without hemophilia: a meta-analysis of randomized control trials

1 reference

12 December 2020

Stroke risk in atrial fibrillation patients on warfarin

1 reference

12 December 2020

Prothrombin complex concentrate (Beriplex P/N) for emergency anticoagulation reversal: a prospective multinational clinical trial

1 reference

12 December 2020

Low-Dose Vitamin K Therapy in Excessively Anticoagulated Patients: A Dose-Finding Study

1 reference

12 December 2020

Duration of anticoagulation following venous thromboembolism: a meta-analysis

1 reference

12 December 2020

Impact of pre-treatment INR level on the effect of intravenous low dose vitamin K in patients with excessive anticoagulation.

1 reference

12 December 2020

Hemorrhagic complications of anticoagulant and thrombolytic treatment: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).

1 reference

12 December 2020

Progression of warfarin-associated intracerebral hemorrhage after INR normalization with FFP.

1 reference

12 December 2020

10.1007/S11239-009-0412-5

Identifiers

DOI

1 reference

21 August 2017

1 reference